ArticleNeurology and therapy2025

Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot Study.

Barbara Risi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.